4th NovAliX Conference

Biophysics in Drug Discovery 2017

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Strasbourg, France    June 6-9, 2017

Committee


Conference Chairman

Chairman

Dr Jean-Paul RENAUD

NovAliX & Ribostruct, Illkirch, France

Scientific Committee

Members

Dr Jim BRYSON

Bristol-Myers-Squibb, Princeton, United States

Dr Chun-wa CHUNG

GlaxoSmithKline, Stevenage, United Kingdom

Prof. Helena DANIELSON

Uppsala University, Uppsala, Sweden

Dr Ursula EGNER

Bayer, Berlin, Germany

Dr Michael HENNIG

leadXpro, Villigen, Switzerland

Dr Geoff HOLDGATE

AstraZeneca, Macclesfield, United Kingdom

Prof. Rod HUBBARD

University of York & Vernalis, Cambridge, United Kingdom

Dr Sandra JACOB

Novartis, Basel, Switzerland

Dr Herbert NAR

Boehringer Ingelheim, Biberach, Germany

Dr Jean-Paul RENAUD

NovAliX & Ribostruct, Illkirch, France